Dornase alfa in young patients with cystic fibrosis - Reply

被引：0
|
作者：
Quan, JM [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
来源：
JOURNAL OF PEDIATRICS | 2002年 / 141卷 / 06期
关键词：
D O I：
10.1067/mpd.2002.128755
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：838 / 839
页数：2
相关论文
共 50 条
  • [31] THE EFFECT OF INTRANASAL DORNASE ALFA ON CHRONIC SINUSITIS IN PATIENTS WITH CYSTIC FIBROSIS: A PILOT STUDY
    Lahiri, T.
    Herrington, H.
    Diehl, S.
    Landrigan, G.
    PEDIATRIC PULMONOLOGY, 2012, 47 : 354 - 354
  • [32] ASSOCIATION OF DORNASE ALFA (PULMOZYME) ADHERENCE WITH MULTIPLE CLINICAL OUTCOMES IN PATIENTS WITH CYSTIC FIBROSIS
    Schwartz, M. S.
    Warren, W.
    McClure, M.
    Greene, C.
    Graff, G.
    PEDIATRIC PULMONOLOGY, 2010, : 369 - 369
  • [33] Dornase alfa in the treatment of cystic fibrosis in Europe: A report from the Epidemiologic Registry of Cystic Fibrosis
    Hodson, ME
    McKenzie, S
    Harms, HK
    Koch, C
    Mastella, G
    Navarro, J
    Strandvik, B
    PEDIATRIC PULMONOLOGY, 2003, 36 (05) : 427 - 432
  • [34] THE COST EFFECTIVENESS OF DORNASE ALFA VERSUS INHALED TOBRAMYCIN IN THE MANAGEMENT OF PATIENTS WITH CYSTIC FIBROSIS
    Rezaei, S.
    Taheri, S.
    Yousefi, N.
    Peiravian, F.
    VALUE IN HEALTH, 2019, 22 : S876 - S876
  • [35] Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation
    Bakker, E. M.
    Volpi, S.
    Salonini, E.
    van der Wiel-Kooij, E. C.
    Sintnicolaas, C. J. J. C. M.
    Hop, W. C. J.
    Assael, B. M.
    Merkus, P. J. F. M.
    Tiddens, H. A. W. M.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (06) : 1328 - 1335
  • [36] Pharmacoeconomic Assessment of the Application of Dornase Alfa in the Treatment of Lung Generation in Patients with Cystic Fibrosis
    Nemchenko, Alla S.
    Panfilova, Anna L.
    Podgaina, Maryna V.
    Zaytzeva, Yuliya L.
    Balynska, Maryna V.
    ASIAN JOURNAL OF PHARMACEUTICS, 2018, 12 (01) : 374 - 381
  • [37] DORNASE ALFA FOR CYSTIC-FIBROSIS - PATIENTS SHOULD NOT BE DENIED A SAFE, EFFECTIVE TREATMENT
    HODSON, ME
    ROSENTHAL, M
    WALLIS, C
    STABLEFORTH, DE
    CONWAY, SP
    LITTLEWOOD, JM
    BRITISH MEDICAL JOURNAL, 1995, 310 (6993): : 1533 - 1533
  • [38] Withdrawal of dornase alfa increases ventilation inhomogeneity in children with cystic fibrosis
    Voldby, Christian
    Green, Kent
    Philipsen, Lue
    Sandvik, Rikke Mulvad
    Skov, Marianne
    Buchvald, Frederik
    Pressler, Tacjana
    Nielsen, Kim Gjerum
    JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (06) : 949 - 956
  • [39] Dornase Alfa for Non-Cystic Fibrosis Pediatric Pulmonary Atelectasis
    Thornby, Krisy-Ann
    Johnson, Ashley
    Axtell, Samantha
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (08) : 1040 - 1049
  • [40] Is Bronchoscopic Lung Lavage With Dornase Alfa A Therapeutic Option In Cystic Fibrosis?
    Nobuo, M. S. D. P. F.
    Pedrao, N. B.
    Athanazio, R. A.
    Rached, S. Z.
    Carvalho-Pinto, R. M.
    Cukier, A.
    Stelmach, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
12345